2006 Growth Spurs Expansion7 February 2007
BUBENDORF, Switzerland - CARBOGEN AMCIS AG has announced plans for a number of operational enhancements in response to positive results in the 12 months ending December 2006.
"We are extremely pleased with our growth in 2006," said Mark Griffiths CEO, CARBOGEN AMCIS. "It is the result of the hard work and dedication of our employees. Our growth is also an indication that our customers are confident Dishman’s acquisition of CARBOGEN AMCIS will enhance the business."
The company was acquired in Q3, 2006, by Dishman Pharmaceuticals and Chemicals Ltd., which is headquartered in Ahmedabad, India.
"By executing our strategies of key account management and expansion of our customer base in the U.S. and Europe, revenue for the period saw substantial double-digit growth over our strong 2005 results," added Steve Cracknell, commercial director, CARBOGEN AMCIS.
Chief among the number of key changes to support continued growth in 2007/08 is the introduction of 24/7 operation at the manufacturing unit at Bubendorf. In addition, the company will add production capacity with the introduction of a third shift in the High Potency Kilo Plant at Bubendorf, and institute full two-shift operations at the manufacturing units in Aarau and Neuland, Switzerland. These changes are in direct response to increased customer demand.
Coupled with these additions, CARBOGEN AMCIS will continue to deploy technology enhancing its ability to meet customer needs in chemical development and niche manufacturing. Microreactors will be introduced to the Neuland site, and the new High Potency Analytical and QC laboratory in Bubendorf will be put into operation in Q1 2007. Additional capability will also be introduced into the chromatography group at Aarau where CARBOGEN AMCIS maintains a center of chromatography expertise. Further analytical tools will also be implemented to assist in providing data to speed up the chemical development cycle.
CARBOGEN AMCIS AG is the supplier of choice for the pharmaceutical industry for technical development and niche scale production of active pharmaceutical ingredients. Innovative solutions for customers and application of new technology differentiate CARBOGEN AMCIS from its competition.
CARBOGEN AMCIS AG is owned by Dishman Pharmaceuticals and Chemicals Ltd., Ahmedabad, India.
Source: CARBOGEN AMCIS AG, Bubendorf, Switzerland